{"transactions":[{"id":2478295,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-12-11T02:00:47.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 22,336 of the shares subject to the option vest and become exercisable as of 12:01 a.m. Eastern time on the date of the issuer's 2022 Annual Meeting of Stockholders and the remaining 44,664 shares vest and become exercisable in equal monthly installments over the following 24 months, subject to continued service through each vesting date."}],"balance_after":67000,"derivative":{"exercise_price":5.94,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001140361-21-041285","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121041285/form4.xml","form_type":"4"}},{"id":3973133,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T20:07:20.000Z","date":"2018-03-30","kind":"other","acquired":true,"shares":528,"price":3.2,"value":1689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock"}],"balance_after":8222,"source":{"system":"sec-edgar","filing":"0001213900-18-003989","document":"f4033018mohr_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018003989/f4033018mohr_delmar.xml","form_type":"4"}},{"id":4112176,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T21:53:32.000Z","date":"2017-12-31","kind":"other","acquired":true,"shares":528,"price":3.2,"value":1689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7694,"source":{"system":"sec-edgar","filing":"0000905718-18-000010","document":"mohr_form4dec312017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571818000010/mohr_form4dec312017.xml","form_type":"4"}},{"id":4197771,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T23:51:35.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":528,"price":3.2,"value":1689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7166,"source":{"system":"sec-edgar","filing":"0001213900-17-010208","document":"f4092917mohr_delmarpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017010208/f4092917mohr_delmarpharm.xml","form_type":"4"}},{"id":4259072,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2017-07-12T01:35:08.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."}],"balance_after":200000,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-17-007478","document":"f4070717mohr_delmarpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007478/f4070717mohr_delmarpharma.xml","form_type":"4"}},{"id":4259071,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2017-07-12T01:35:08.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12,000 options vest on June 30, 2018, and 3,000 options vest each three months thereafter starting September 30, 2018."}],"balance_after":36000,"derivative":{"exercise_price":2.11,"exercise_date":"2020-06-30","expiration_date":"2027-07-07","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001213900-17-007478","document":"f4070717mohr_delmarpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007478/f4070717mohr_delmarpharma.xml","form_type":"4"}},{"id":4264461,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T18:29:02.000Z","date":"2017-06-30","kind":"other","acquired":true,"shares":528,"price":3.2,"value":1689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":6638,"source":{"system":"sec-edgar","filing":"0001213900-17-007147","document":"f4063017mohr_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007147/f4063017mohr_delmarpharma.xml","form_type":"4"}},{"id":4271065,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-28T15:33:19.000Z","date":"2017-06-26","kind":"purchase","acquired":true,"shares":4167,"price":3.6,"value":15001.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $20,000. Reported price is based on exchange rate of 0.75."}],"balance_after":6110,"source":{"system":"sec-edgar","filing":"0001213900-17-006884","document":"f4062617mohr_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017006884/f4062617mohr_delmarpharma.xml","form_type":"4"}},{"id":4365209,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-03T22:15:33.000Z","date":"2017-03-31","kind":"other","acquired":true,"shares":528,"price":3.2,"value":1689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1943,"source":{"system":"sec-edgar","filing":"0001213900-17-003270","document":"f4033117mohr_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017003270/f4033117mohr_delmar.xml","form_type":"4"}},{"id":4507882,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T18:54:34.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":528,"price":3.2,"value":1689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":1415,"source":{"system":"sec-edgar","filing":"0001213900-17-000021","document":"f4123116mohr_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017000021/f4123116mohr_delmar.xml","form_type":"4"}},{"id":4584398,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":132568,"kind":"person","name":"Mohr Erich","position":1,"cik":"0001298170","reported_name":"Mohr Erich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T14:20:30.000Z","date":"2016-10-03","kind":"other","acquired":true,"shares":528,"price":3.2,"value":1689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":887,"source":{"system":"sec-edgar","filing":"0001213900-16-017291","document":"f4100316mohr_delmarpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390016017291/f4100316mohr_delmarpharm.xml","form_type":"4"}}]}